ESR1 and inflammatory breast carcinoma: Knock-down of NEMO in ER+/PR+ DCIS.COM cells prior to intraductal xenografting increased invasive progression of DCIS lesions in vivo, implicating NEMO as a potential tumor suppressor regulated by E2 and P4 in the transition of DCIS to IBC [100].